Current developments in spinal cord injury research

Spine Journal

Volumn 2, Issue 2, 2002, Pages 116-128

  Carlson, Gregory D ^a,b   Gorden, Carey ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Primary injury; Secondary injury; Somatosensory evoked potential recovery; Spinal cord decompression; Spinal cord injury

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CALPAIN; FIBROBLAST GROWTH FACTOR 2; FREE RADICAL; GANGLIOSIDE GM1; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY IN 1; NALOXONE; NERVE GROWTH FACTOR; NEUROTRANSMITTER; NEUROTROPHIN 3; PLACEBO; TIRILAZAD; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BIOCHEMISTRY; COMPLICATION; DECOMPRESSION SURGERY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; EVOKED SOMATOSENSORY RESPONSE; EXPERIMENTATION; HOSPITALIZATION; HUMAN; LIPID PEROXIDATION; MALE; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MORTALITY; MYELITIS; NEUROLOGIC DISEASE; NEUROSCIENCE; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PEER REVIEW; RAT; REGENERATION; REHABILITATION; REVIEW; SIDE EFFECT; SOCIAL ASPECT; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA; TIME; TISSUE PRESERVATION; TREATMENT PLANNING;

DECOMPRESSION, SURGICAL; EVOKED POTENTIALS, SOMATOSENSORY; HUMANS; SPINAL CORD INJURIES;

EID: 0037017477     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-9430(01)00029-8     Document Type: Review

References (154)

1. Indication, surgical technique, and results of 100 surgically-treated fractures and fracture-dislocations of the cervical spine
2. Spinal cord energy metabolism following compression trauma to the feline spinal cord
3. Cerebrospinal fluid lactate and electrolyte levels following experimental spinal cord injury
4. Chemical and cellular mediators in spinal cord injury
5. Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury
6. Effect of delayed administration of U74006F on recovery of locomotor function after experimental spinal cord injury
7. Experimental models for spinal cord injury research: Physical and physiological considerations
8. Synergistic effect of basic fibroblast growth factor and methylprednisolone on neurological function after experimental spinal cord injury
9. Pathology of experimental spinal cord trauma: Ultrastructure of axons and myelin
10. Ultrastructural pathology of axons and myelin in calcium-induced myelopathy
11. Role of calpain in spinal cord injury: Effects of calpain and free radical inhibitors
12. Lipid peroxidation in experimental spinal cord injury: Time-level relationship
13. A comparison of YM-146743, U-50488H, and nalmefene after spinal cord injury in the rat
14. Experimental spinal cord injury in monkeys: Comparison of steroids and local hypothermia
15. Delayed demyelination and macrophage invasion: A candidate for secondary cell damage in spinal cord injury
16. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurologic function in NASCIS 2
17. Administration of methyl-prednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury
18. Treatment of acute spinal cord injury with methyl-prednisolone: Results of a multicenter, randomized clinical trial
19. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury
20. Involvement of lipid peroxidation in CNS injury
21. A new 21-amino-steriod antioxidant lacking glucocorticoid activity stimulates adrenocorticotropin secretion and blocks arachidonic acid release from mouse pituitary tumor (AtT-20) cells
22. Calcium enhances in vitro free radical-induced damage to brain synaptosomes, mitochondria, and cultured spinal cord neurons
23. Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury
24. Novel 21-amino steriods as potent inhibitors of iron-dependent lipid peroxidation
25. Transplants and neurotrophic factors prevent atrophy of mature CNS neurons after spinal cord injury
26. Intervention strategies to enhance anatomical plasticity and recovery of function after spinal cord injury
27. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors
28. Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat
29. An electron-microscopic analysis of axonal alterations following blunt contusion of the spinal cord of the rhesus monkey (Macaca mulatta)
30. A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device
31. A neuroanatomical analysis of spinal cord injury in the rhesus monkey
32. Embryonic stem cell-derived glial precursors: A source of myelinating transplants
33. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination
34. Effect of timing of stabilization on length of stay and medical complications following spinal cord injury
35. Perfusion limited recovery after spinal cord injury
36. Vascular re-perfusion and neural preservation after spinal cord injury
37. Early time-dependent decompression for spinal cord injury: Vascular mechanisms of recovery
38. Viscoelastic relaxation and regional blood flow response to spinal cord compression and decompression
39. Acute inflammatory response in spinal cord following impact injury
40. Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading
41. Caspase and calpain substrates: Roles in synaptic plasticity and cell death
42. Methylprednisolone administration improves exonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord
43. Spinal cord repair in adult paraplegic rats: Partial restoration of hind limb function
44. A new surgical technique that allows proximodistal regeneration of 5-HT fibers after complete transection of the rat spinal cord
45. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death
46. The effects of methylprednisolone and the ganglioside GM-1 on acute spinal cord injury in rats
47. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys
48. Spinal cord injury: Review of basic and applied research
49. Oxygen free radicals in central nervous system ischemia and trauma
50. Recent trends in mortality and causes of death among persons with spinal cord injury
51. Fetal spinal cord transplants support growth of supraspinal and segmental projections after cervical spinal cord hemisection in the neonatal rat
52. Fetal spinal cord transplants support the development of target reaching and coordinated postural adjustments after neonatal cervical spinal cord injury
53. The microvasculature in transitory traumatic paraplegia. An electron microscopic study of the monkey
54. Transitory traumatic paraplegia: Electron microscopy of early alterations in myelinated nerve fibers
55. The value of decompression for acute experimental spinal cord compression injury
56. Experimental injury of the spinal cord
57. Pathological findings in acute experimental spinal cord trauma
58. Medical rehabilitation length of stay and outcomes for persons with traumatic spinal cord injury-1990-1997
59. Extrusion of an intervertebral disc associated with traumatic subluxation or dislocation of cervical facets. Case report
60. Apoptosis after traumatic human spinal cord injury
61. Opioid and nonopioid actions mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury
62. TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: Dose-response studies
63. Opiate antagonist improves neurologic recovery after spinal injury
64. Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats
65. Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury
66. Pharmacological treatment of central nervous system trauma
67. Endorphins in experimental spinal injury: Therapeutic effect of naloxone
68. The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow
69. Protection against postischemic spinal cord injury using a new 21-aminosteroid
70. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebral spinal fluid drainage
71. Effects of macrophage transplantation in the injured adult rat spinal cord: A combined immunocytochemical and biochemical study
72. Recovery of motor function after spinal cord injury-A randomized placebo-controlled trial with GM-1 ganglioside
73. GM-1 ganglioside in human spinal cord injury
74. Recovery of motor function after spinal cord injury-A randomized placebo-controlled trial with GM-1 ganglioside
75. Chemokine antagonist infusion attenuates cellular infiltration following spinal cord contusion injury in rat
76. Characteristics of human fetal spinal cord grafts in the adult rat spinal cord: Influences of lesion and grafting conditions
77. Pharmacological management of spinal cord injury: Current status of drugs designed to augment functional recovery of the injured human spinal cord
78. Pharmacological strategies in the treatment of spinal cord injuries: A critical review
79. Influence of IN-1 antibody and acidic FGF-fibrin glue on the response of injured corticospinal tract axons to human Schwann cell grafts
80. Improvement in posttraumatic spinal cord blood flow with a combination of a calcium channel blocker and a vasopressor
81. Decompression of the spinal cord improves recovery after acute experimental spinal cord compression injury
82. Free radicals in CNS injury
83. Effects of the 21-aminosteroid U74006F on post-traumatic spinal cord ischemia in cats
84. A non-glucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage
85. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury
86. Correlation between attenuation of posttraumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006F: Evidence for an in vivo antioxidant mechanism
87. Management of cervical spine trauma in Southern California
88. Secondary injury and acidosis
89. Behavioural consequences of oligodendrocyte progenitor cell transplantation into experimental demyelinating lesions in the rat spinal cord
90. Reactions of neurons to injury
91. Interaction of contact velocity and cord compression in determining severity of spinal cord injury
92. Treatment with genetically engineered fibroblasts producing NGF or BDNF can accelerate recovery from traumatic spinal cord injury in the adult rat
93. Autoregulation of spinal cord blood flow
94. Experimental acute balloon compression of the spinal cord. Factors affecting disappearance and return of the spinal evoked response
95. Lipid peroxidation in experimental spinal cord injury. Comparison of treatment with Ginkgo biloba, TRH and methylprednisolone
96. Early versus delayed stabilization after cervical spinal cord injury
97. Ganglioside structures and distribution: Are they localized at the nerve ending?
98. Neuroprotective effects of basic fibroblast growth factor following spinal cord contusion injury in the rat
99. Hemodynamic parameters in patients with acute cervical cord trauma: Description, intervention, and prediction of outcome
100. Anterior decompression in cervical spine trauma: Does the timing of surgery affect the outcome
101. Chemical characteristics of spinal cord edema in cats: Effects of steroids on potassium depletion
102. Neurotoxicity of glutamate at the concentration released upon spinal cord injury
103. Neuronal and glial apoptosis after traumatic spinal cord injury
104. Regulation of total and regional spinal cord blood flow
105. Deterioration following spinal cord injury: A multicenter study
106. Extracellular acidity potentiates AMPA receptor-mediated cortical neuronal death
107. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord
108. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord
109. Neuronophagia by leukocytes in experimental spinal cord injury
110. Neurotrophic factors in central nervous system trauma
111. Dynamics of extracellular calcium activity following contusion of the rat spinal cord
112. Dexamethasone prevents loss of axonal conduction and reflex activity, and reduces spread of structural damage in acute spinal cord trauma
113. Recent demographic and injury trends in people served by the Model Spinal Cord Injury Care Systems
114. Survival effects of BDNF and NT-3 on axotomized rubrospinal neurons depend on the temporal pattern of neurotrophin administration
115. On CNS repair and protection strategies: Novel approaches with implications for spinal cord injury and Parkinson's disease
116. Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries
117. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats
118. Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord
119. Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury
120. Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants
121. 2+ influx upregulate calpain and induce apoptosis in PC12 cells
122. Cervical spine trauma
123. Histopathologic clues to the pathways of neuronal death following ischemia/hypoxia
124. Implications of p53 protein expression in experimental spinal cord injury
125. Timing of surgical decompression and fixation of acute spinal fractures
126. Loss of autoregulation and posttraumatic ischemia following experimental spinal cord trauma
127. Free radicals and brain damage
128. Monosialoganliosides, neuroprotection, and neuronal repair processes
129. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury
130. Experimental spinal cord injury: A dynamic and verifiable injury device
131. An electromechanical spinal injury technique with dynamic sensitivity
132. Effect of thyrotropin-releasing hormone (TRH) in experimental spinal cord injury: A quantitative histopathologic study
133. Superoxide radicals play important roles in the pathogenesis of spinal cord injury
134. Spinal cord compression studies. III. Time limits for recovery after gradual compression in dogs
135. Spinal cord compression studies II. Time limits for recovery after acute compression in dogs
136. Regeneration of injured axons in the adult mammalian central nervous system
137. Experimental and clinical studies of the pathophysiology and management of acute spinal cord injury
138. Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury
139. Apoptosis following spinal cord injury in rats and preventative effect of N-methyl-D-aspartate receptor antagonist
140. Histopathology of transitory traumatic paraplegia in the monkey
141. Successful improvement of blood pressure, cardiac output, and spinal cord blood flow after experimental spinal cord injury
142. Differential activation of microglia after experimental spinal cord injury
143. Effects of oxygen radicals on cerebral arterioles
144. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors
145. Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice
146. Role of N-methyl-D-aspartate receptor in acute spinal cord injury
147. Methylprednisolone treatment of acute spinal cord injury: An introduction
148. Recovery mechanisms in spinal cord injury: Implications for regenerative therapy
149. Role of calcium in central nervous system injuries
150. Secondary injury mechanisms in acute spinal cord injury
151. Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury
152. Effect of naloxone on posttraumatic ischemia in experimental spinal contusion
153. Potassium and calcium changes in injured spinal cords
154. Clinical applications of pharmacologic therapies for spinal cord injury